Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.

Patel P, Balise R, Srinivas S.

Onkologie. 2012;35(10):588-91. doi: 10.1159/000342695. Epub 2012 Sep 24.

PMID:
23038230
2.

Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.

Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG.

Oncol Rep. 1998 Nov-Dec;5(6):1425-9.

PMID:
9769381
3.

[Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].

Neumann A, Keller T, Jocham D, Doehn C.

Aktuelle Urol. 2011 Sep;42(5):311-5. doi: 10.1055/s-0031-1271545. Epub 2011 Aug 1. German.

PMID:
21809268
4.

Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.

Kawai K, Kojima T, Miyanaga N, Hattori K, Hinotsu S, Shimazui T, Akaza H.

Int J Urol. 2005 Mar;12(3):284-9.

5.

Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.

Kamoto T, Satomura S, Yoshiki T, Okada Y, Henmi F, Nishiyama H, Kobayashi T, Terai A, Habuchi T, Ogawa O.

Jpn J Clin Oncol. 2002 Nov;32(11):472-6.

PMID:
12499420
6.

[Two cases of testicular tumors with high alpha-fetoprotein levels: a case report].

Funahashi M, Tuchiya F, Makiyama K, Sugiura S, Miyoshi Y, Kishida T, Ogawa T, Uemura H, Yao M, Kubota Y.

Hinyokika Kiyo. 2005 Feb;51(2):133-7. Japanese.

7.

[Clinical presentation of testicular germinal cancer].

Fernández Gómez JM, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, Escaf Barmadah S, García Rodríguez J, Pérez García FJ, Rodríguez Faba O, Jalón Monzón A.

Arch Esp Urol. 2002 Oct;55(8):915-22. Review. Spanish.

PMID:
12455282
8.

Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.

Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.

J Surg Oncol. 2006 Dec 1;94(7):619-23.

PMID:
17111392
9.

[Management of testicular seminoma with elevation of alpha fetoprotein. A case report].

Durand X, Vedrine L, Deligne E, Desfemmes FR, Ceccaldi B, Houlgatte A.

Prog Urol. 2008 Mar;18(3):190-2. doi: 10.1016/j.purol.2007.12.009. Epub 2008 Apr 8. French.

PMID:
18472076
10.

Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer.

Klepp O, Dahl O, Flodgren P, Stierner U, Olsson AM, Oldbring J, Nilsson S, Daehlin L, Tørnblom M, Småland R, Starkhammar H, Abramsson L, Wist E, Raabe N, Edekling T, Cavallin-Ståhl E.

Eur J Cancer. 1997 Jun;33(7):1038-44.

PMID:
9376184
11.

Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.

Otto T, Virchow S, Fuhrmann C, Steinberg F, Streffer C, Goepel M, Rübben H.

Urol Res. 1997;25(2):121-4.

PMID:
9144879
12.

Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.

Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.

Cancer. 2003 Oct 15;98(8):1635-42.

13.

[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors].

Yamazaki H, Kondo N, Imanaka K, Kuroda A, Nakauchi K, Machida T.

Nihon Hinyokika Gakkai Zasshi. 1990 Jul;81(7):1010-6. Japanese.

14.

Surveillance study for clinical stage I testicular seminomas and nonseminomatous germ cell tumors.

Suzuki K, Orikasa S, Hoshi S, Yoshikawa K, Imai Y, Aizawa M, Nishimura Y, Okada Y, Ohnuma T, Ogata Y.

Int J Urol. 1998 Nov;5(6):568-74.

15.

[The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].

Calaminus G, Vesterling-Hörner D, Bökkerink JP, Gadner H, Günther G, Haas HJ, Jürgens H, Teske C, Göbel U.

Klin Padiatr. 1991 Jul-Aug;203(4):246-50. German.

PMID:
1719268
17.

The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.

Miller JS, Lee TK, Epstein JI, Ulbright TM.

Am J Surg Pathol. 2009 Sep;33(9):1293-8. doi: 10.1097/PAS.0b013e3181a3166d.

PMID:
19461507
19.

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.

Miki T, Kamoi K, Fujimoto H, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto M, Naito S, Fukumori T, Kubota Y, Takahashi S, Mikami K, Homma Y.

Int J Urol. 2014 Aug;21(8):S1-6. doi: 10.1111/iju.12441. Epub 2014 Apr 13.

20.

Serum markers in germ cell neoplasms.

Bartlett NL, Freiha FS, Torti FM.

Hematol Oncol Clin North Am. 1991 Dec;5(6):1245-60. Review.

PMID:
1723408

Supplemental Content

Support Center